Hottod you have summarised yesterdays CR quite nicely. I agree there are positives. POHs Board has been decisive in securing POHs financial future- no dilly dallying- just get on with what must be done. I like this new board and I really believe that the management & Board mistakes of the Esra era will not be repeated.
Institutional Investors partaking in the CR have demonstrated confidence in POHs clinical program and commercial prospects. Article in the Australian today describes POH as a "struggling Biotech". I'm increasingly confident that POH will not be associated with that term going forward.
So...Im resigned to the fact that I will need to raise my targeted exit price to cover yesterdays dilution. So be it- POH has enough in the pipeline to deliver me my price in spades- POHs Acne results should be the panacea to turn market sentiment positive. A couple of days or weeks and we will know what POHs TPM tech of 2014 can do in a Phase 2- bring it on POH!!!
Hottod you have summarised yesterdays CR quite nicely. I agree...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $16.54K | 5.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 96791453 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 58594028 | 16 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |